Skip to content
healthcare.dev

Lamotrigine

NDC 68382-981, Lamotrigine, tablet, extended release, from Zydus Pharmaceuticals USA Inc..

Product NDC
68382-981
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207763
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68382-981 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE100 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
68382-981-0568382098105500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-981-05)
68382-981-066838209810630 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-981-06)
68382-981-166838209811690 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-981-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eb436371-d188-4803-a864-07b90c357e57
  • NADAC price for package 68382098106

    GET /v1/drugs/nadac/68382098106

Use it

Look up 68382-981 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68382-981 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68382-981. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.